Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Blog Highlights Debate Around South Africa’s Delayed Patent Reforms

The Center for Global Health Policy’s “Science Speaks” blog discusses details on “Pharmagate,” a plan with the aim “to derail proposed patent reforms in South Africa, [however,] those involved indicated that the plan, dubbed ‘genocidal’ by South Africa Health Minister Aaron Motsoaledi, was the product of a misunderstanding…” (Barton, 2/11).

Australia Stands With S. Africa In Defense Of TRIPS Flexibilities

Huffington Post: Unlikely Allies Sandeep Kishore, chair of the Advisory Council of the Young Professionals Chronic Disease Network, and Kavitha Kolappa, a psychiatry resident at Massachusetts General/McLean Program “The recent Executive Board proceedings of the World Health Organization (January 20-25, 2014) provided new ground for unlikely allies South Africa and…

Lawmakers ‘Falling Short’ In Improving Access To Medicines Worldwide

“In his State of the Union address last week, President Obama nominally reaffirmed his commitment to universal health care, citing the success of the Affordable Care Act. Despite his dedication to free and fair medical services for Americans, he failed to comment on the essential life-saving global medicine funding programs…

U.S. Expresses Concern Over India’s Proposal To Allow More Generic Drug Production

Reuters: U.S. fears for patents on next-generation drugs in India “The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on…

India’s Supreme Court Rules Against Novartis AG In ‘Landmark’ Patent Case

“India’s Supreme Court on Monday rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines,” the Associated Press reports. “Novartis had…

Reuters Examines Implications Of India’s Novartis Patent Ruling For Big Pharma

Reuters examines the implications of India’s Supreme Court ruling to overturn a patent on Novartis’s cancer treatment Glivec for the pharmaceutical industry in India and across the developing world. “Stung by a landmark patent defeat, Western drug makers will be wary about launching new products in India, but they cannot…

Five Japanese Drug Makers Form PPP To Accelerate Development Of Drugs, Vaccines For Infectious Diseases

“Five Japanese pharmaceutical giants are teaming up with the Bill & Melinda Gates Foundation and Japan’s government to develop new medicines, vaccines, and diagnostics for infectious diseases in developing countries,” GENNews reports (4/8). “The Global Health Innovative Technology (GHIT) fund will see Takeda, Astellas, Daiichi-Sankyo, Eisai and Shionogi partner with [the] non-profit…

Health Advocates Working To Lower Cost Of HCV Medicines In LMICs, Reuters Reports

“A new battle is looming over access to antiviral medicines in developing countries — this time for treating hepatitis C [HCV] — more than a decade after a global showdown over the price of AIDS drugs in Africa,” Reuters reports. “Modern pills being launched in western markets could cure the…

Multilateral Banks Could Support LMICs’ Anti-Tobacco Policies

Noting a recent report in the New York Times about “Big Tobacco’s use of international trade and investment agreements to undermine anti-tobacco policies in low- and middle-income countries [LMICs],” Amanda Glassman, senior fellow and director of global health policy at the Center for Global Development (CGD), and Bill Savedoff, a…